13F COMBINATION REPORT
Nan Fung Group Holdings Ltd
Quarter ended Q2 2023 · Filed May 12, 2023 · Accession 0001012975-23-000216
Total Value
$147.0M
Positions
44
Other Managers
2
Confidential Omitted
No
Holdings (44)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KARUNA THERAPEUTICS INC | 48576A100 | 225,688 | $41.0M | 27.89% |
| 2 | ILLUMINA INC | ILMN | 119,196 | $27.7M | 18.86% |
| 3 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 368,665 | $12.0M | 8.19% |
| 4 | SEAGEN INC | SE | 47,096 | $9.5M | 6.49% |
| 5 | OCULIS HOLDING AG | OCSAW | 651,100 | $4.8M | 3.29% |
| 6 | EXSCIENTIA PLC | 30223G102 | 859,892 | $4.6M | 3.10% |
| 7 | SOMALOGIC INC | 83444K105 | 1,696,558 | $4.3M | 2.94% |
| 8 | XENON PHARMACEUTICALS INC | XENE | 114,380 | $4.1M | 2.79% |
| 9 | REPLIMUNE GROUP INC | REPL | 189,339 | $3.3M | 2.28% |
| 10 | MERUS N V | N5749R100 | 151,000 | $2.8M | 1.89% |
| 11 | IVERIC BIO INC | 46583P102 | 111,984 | $2.7M | 1.85% |
| 12 | CHINOOK THERAPEUTICS INC | 16961L106 | 113,950 | $2.6M | 1.80% |
| 13 | BEIGENE LTD | BEIGF | 12,022 | $2.6M | 1.76% |
| 14 | RANI THERAPEUTICS HLDGS INC | RANI | 493,584 | $2.5M | 1.73% |
| 15 | INCYTE CORP | INCY | 34,391 | $2.5M | 1.69% |
| 16 | BIOMEA FUSION INC | BMEA | 60,000 | $1.9M | 1.27% |
| 17 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,166,952 | $1.6M | 1.10% |
| 18 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 136,655 | $1.6M | 1.08% |
| 19 | GALERA THERAPEUTICS INC | GRTX | 613,223 | $1.6M | 1.07% |
| 20 | GITLAB INC | GTLB | 36,952 | $1.3M | 0.86% |
| 21 | EXELIXIS INC | EXEL | 64,200 | $1.2M | 0.85% |
| 22 | MERCADOLIBRE INC | MELI | 904 | $1.2M | 0.81% |
| 23 | ENTRADA THERAPEUTICS INC | TRDA | 73,582 | $1.1M | 0.73% |
| 24 | AEROVATE THERAPEUTICS INC | 008064107 | 47,936 | $966,869 | 0.66% |
| 25 | BIOMARIN PHARMACEUTICAL INC | BMRN | 7,215 | $701,587 | 0.48% |
| 26 | EARGO INC | 270087208 | 147,904 | $692,191 | 0.47% |
| 27 | FIBROGEN INC | 31572Q808 | 34,106 | $636,418 | 0.43% |
| 28 | DBV TECHNOLOGIES S A | DBVTF | 370,950 | $626,906 | 0.43% |
| 29 | KALVISTA PHARMACEUTICALS INC | KALV | 78,720 | $618,739 | 0.42% |
| 30 | RHYTHM PHARMACEUTICALS INC | RYTM | 32,520 | $580,157 | 0.39% |
| 31 | TRAVERE THERAPEUTICS INC | TVTX | 25,606 | $575,879 | 0.39% |
| 32 | ACADIA PHARMACEUTICALS INC | ACAD | 29,984 | $564,299 | 0.38% |
| 33 | ARGENX SE | ARGX | 1,430 | $532,789 | 0.36% |
| 34 | ASCENDIS PHARMA A/S | ASND | 4,168 | $446,893 | 0.30% |
| 35 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1,182 | $286,351 | 0.19% |
| 36 | AFFIMED N V | N01045108 | 372,472 | $277,715 | 0.19% |
| 37 | ALX ONCOLOGY HLDGS INC | ALXO | 41,950 | $189,614 | 0.13% |
| 38 | BIOCRYST PHARMACEUTICALS INC | BCRX | 17,847 | $148,844 | 0.10% |
| 39 | SATSUMA PHARMACEUTICALS INC | 80405P107 | 177,900 | $124,263 | 0.08% |
| 40 | KODIAK SCIENCES INC | KOD | 19,622 | $121,656 | 0.08% |
| 41 | NURIX THERAPEUTICS INC | NRIX | 11,500 | $102,120 | 0.07% |
| 42 | ABCELLERA BIOLOGICS INC | ABCL | 12,521 | $94,408 | 0.06% |
| 43 | CERUS CORP | CERS | 14,172 | $42,091 | 0.03% |
| 44 | INVITAE CORP | 46185L103 | 11,337 | $15,305 | 0.01% |